Acadia Pharmaceuticals

ACADNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$5.033 B

$29.21 +2.67%

Close of 7 Aug 2026

Revenue

$1.07B

#1492 by revenue

Earnings

$391.0M

#727 by earnings

Shares outstanding

172,305,518

Latest filing cover page

P/E ratio

12.9

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#57Travere TherapeuticsTVTX$5.78B
#58GrifolsGRFS$5.46B
#59Acadia PharmaceuticalsACAD$5.03B
#60Dyne TherapeuticsDYN$4.90B
#61Indivior PharmaceuticalsINDV$4.84B

Where these numbers come from

Share counts and financials for Acadia Pharmaceuticals are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.